D
isorders of the breast in adolescents often reflect normal changes related to endocrine function or benign mass lesions [1] . However, because of increased awareness of breast cancer, pediatricians and surgeons are evaluating increasing numbers of children with breast symptoms [2] , and sonography often is the first diagnostic imaging technique used. The spectrum of sonographic findings encountered in children and adolescents presenting with breast symptoms and the sonographic findings of biopsy-proven fibroadenoma have been described [2] [3] [4] [5] . The purpose of this study was to assess the role of sonography in the diagnosis and management of palpable solid breast masses in adolescents and to correlate the sonographic findings with the histopathologic findings and clinical outcome.
Materials and Methods
Institutional review board approval was ob tained for this HIPAA-compliant retrospective study. A waiver of patient informed consent was obtained. Family history of breast cancer and current history OBJECTIVE. The purpose of this study was to assess the role of sonography in the diagnosis and management of palpable solid breast masses in adolescents and to correlate the sonographic findings with the histopathologic findings and clinical outcome.
MATERIALS AND METHODS.
A retrospective study was conducted with the breast sonograms of 20 adolescent girls [13] [14] [15] [16] [17] [18] [19] years old who presented with palpable breast masses found to be solid at breast sonography. The Stavros sonographic criteria were used to assess the benignity or malignancy of solid breast masses. All sonographic findings were correlated with histopathologic or clinical follow-up findings.
RESULTS. Sonography showed 21 solid masses in 20 patients (one patient had bilateral solid breast masses). All but six solid masses were presumed benign according to the Stavros sonographic criteria. All solid masses were proved benign at histopathologic or clinical follow-up examination.
CONCLUSION. Sonography was not useful for predicting the histologic diagnosis of all solid benign breast masses in adolescent patients. The Stavros sonographic criteria, however, were useful for predicting benignity in 65% of the breast masses on which histopathologic examination was performed. Tissue biopsy may be performed on solid breast masses that do not meet the criteria for benign masses according to the Stavros sonographic criteria. [6] . Individual malignant characteristics of a breast mass were marked hypoechogenicity, angular or spiculated margins, post erior acoustical shadowing, micro calcifications, ductal extension, and microlobulation. The presence of any malignant feature excluded a nodule from benign class ification. A nodule was classified as benign if one of the following three combinations was present: intense and uniform hyperechogenicity, ellipsoid shape with a thin echogenic capsule, or three or fewer gentle macrolobulations associated with a thin echogenic capsule [6] . According to these criteria, 15 of 21 solid masses were classified as benign appearing. The BI-RADS classification of breast lesions on sonography was not used because BI-RADS has historically been used only for adults and is not mandated by the Mammography Quality Standards Act.
The medical records of all 20 patients with 21 breast masses were reviewed. Final diagnosis was achieved with histopathologic findings for 17 (81%) of the 21 breast masses. In the other four cases, the presumed diagnosis of benign breast mass was made after 3-4 months of clinical follow-up.
Results
None of the 20 patients had a family history of breast cancer. One patient had a history of being treated for neuroblastoma. Sonograms showed 21 solid masses in 20 patients with palpable breast masses; one of the patients had presented with simultaneous bilateral breast masses. The Stavros sono graphic criteria for benign features were met by all but six of the solid masses. The six masses were one mass with possible calc ifications that was proved at biopsy to be a benign phyllodes tumor and five masses that had more than three gentle macrolobulations. At biopsy, two of these five masses were proved to be benign fibro adenoma and 
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three to be benign phyllodes tumors. Table 1 shows the sonographic data collected on the 21 solid breast masses. All solid masses had a thin echogenic pseudocapsule. All solid masses were ellipsoid. Eleven masses had no lobulations ( Fig. 1 ), five had two or three gentle macrolobulations, and five had more than three lobulations (Fig. 2) . Mild hypo echogenicity was present in 19 masses ( Fig. 1) , uniform mild hyperechogenicity in one mass (Fig. 3) , and isoechogenicity in one mass. Fifteen masses were homogeneous and six were minimally heterogeneous in echo texture. One of the minimally hetero geneous masses exhibited scattered echo genic foci consistent with calcifications ( Fig. 4) , and another mass had cystic changes with comet tail artifacts ( Fig. 5) . At Doppler interrogation, 19 masses were found to have internal or peripheral vascularity, and two were avascular. Seventeen (81%) of the 21 solid masses were subjected to tissue biopsy. Table 2 illustrates the sonographic features of these 17 solid masses with the tissue diagnoses. Excisional biopsy was performed on 16 of the 17 masses. Of the 16 masses, final diagnoses based on excisional biopsy findings were as follows: nine fibroadenomas, five benign phyllodes tumors, one case of lobular sclerosing hyperplasia, and one case of adenomatous lactational hyperplasia. Two of the benign phyllodes tumors had a previous fine-needle aspiration (FNA) biopsy diagnosis of fibroadenoma. Because the lesions continued to grow for 1 year, ex cisional biopsy was performed, revealing the final diagnosis of benign phyllodes tumor in one case and focal lactational hyperplasia in another. The seventeenth patient underwent FNA biopsy, which revealed fibrocystic changes of normal breast.
Four solid masses in three patients were not subjected to tissue biopsy. All three of these patients and the patient with an FNA biopsy diagnosis of fibrocystic changes of normal breast underwent clinical follow-up for 3-6 months until the breast masses were no longer palpable. Sonographic docu mentation of resolution of these masses was not possible because the patients became lost to follow-up. Vade et al.
Discussion
Pathologic conditions of the breast are rare in children and adolescents [7] . Reportedly, 34% of the children with palpable breast masses have pathologic lesions [5] . Most pediatric breast masses are benign. Regardless of histologic type, 10-40% of clinically detected breast masses in adolescents resolve completely [2] . The most common benign neoplastic breast lesions in children and adolescents are fibroadenoma and benign phyllodes tumors. Other benign solid neo plastic breast lesions include fibroma, he mangioma, papilloma, lymphangioma, and lipoma. Apart from fibroadenoma and benign phyllodes tumors, no benign neoplastic lesion has malignant potential. According to the National Cancer Institute [8] , the age-specific incidence of breast cancer among patients younger than 19 years is less than 25 cases per 100,000 per year.
The American College of Radiology document [9] on appropriateness criteria for palpable breast masses in women younger than 30 years states that the most common use of breast sonography is characterization of breast masses. The document also states that with use of the Stavros sonographic criteria for benign and malignant solid breast masses, a high negative predictive value of 99.5% is possible. A detailed physical exam ination along with breast sonography has been considered sufficient for the correct diagnosis of breast masses in children [10] . The dogma that all discrete breast lumps should be excised has therefore been challenged [2] . We believe that the high prevalence of excisional biopsy of solid breast masses in our study was due to parental anxiety and surgeon concern, as also was found by Bock et al. [11] in a study involving 62 girls with breast symptoms.
Fibroadenomas are benign neoplasms that constitute 50-76% of breast masses in children and adolescents [2, 5, 7, [12] [13] [14] [15] [16] . Fibroadenomas have high cellularity and a biphasic pattern consisting of epithelial and stromal components. The peak age at occurrence of fibroadenoma is 18 years [17] . The cause of fibroadenoma is uncertain, but hormonal influences probably play an important role because a significant pro portion of fibroadenomas change in size with changes in hormonal environment [1] . The course of fibroadenomas varies; 16-37% of the tumors resolve within 1-3 years, 30-40% of those that do not resolve shrink within 5 years, and the rest stop growing when they reach a diameter of 1-3 cm [1, 18, 19] .
The sensitivity of sonography in the diagnosis of fibroadenoma has been reported to be 98% [19] . Sonographically, fibro adenomas may be oval, round, or macro lobulated and have been described as well-circumscribed hypoechoic or anechoic masses that may have areas of necrosis or fluid-filled clefts [3] . Five solid breast masses with typical sonographic features of fibro adenoma in our study were followed clinically until resolution. All of these masses were benign according to the Stavros sonographic criteria, being ellipsoid and having a thin echogenic capsule. Only one of these masses was subjected to FNA biopsy, which showed fibrocystic changes of normal breast. These masses were encountered in adolescents 16-19 years old, and the size range was 1.1-2.6 cm. No sonographic follow-up was performed on these masses to confirm clinical resolution.
Fibroadenomas exhibiting cysts, sclerosing adenosis, epithelial calcifications, or papil lary apocrine changes at histologic examination are classified as complex [20] . Less than 5% of fibroadenomas grow large; the terms giant fibroadenoma and juvenile fibroadenoma are reserved for lesions larger than 10 cm in diameter [3] . Patients with fibroadenomas that have a complex histologic pattern are at increased risk of breast cancer [20, 21] . Sclerosing lobular hyperplasia is a benign tumor that resembles fibroadenoma clinically and is found up to the age of 35 years. These tumors have not been found to have malignant potential [15] . Fibroadenoma is three times as common as sclerosing lobular hyperplasia [15] .
Phyllodes tumors resemble giant fibroadenomas in clinical and sonographic appearance but differ in surgical management and prognosis [22] . The stroma of phyllodes tumors has greater cellular content than does that of fibroadenomas. Phyllodes tumor is an extremely rare breast tumor, constitut ing 0.3-1% of fibroepithelial neoplasms of the breast; most of these tumors occur among women 35-55 years old [22] . Five percent of phyllodes tumors may have evidence of malignancy [4] . The mean size of phyllodes tumors is larger than that of fibroadenomas [22] . Phyllodes tumor probably develops de novo from breast tissue but may originate from a preexisting fibroadenoma, as may have been the case in one of our patients [4] . Phyllodes tumors often are lobulated in con tour, have smooth margins, and are hetero geneous in echotexture, typically without calcification.
Posterior acoustic enhancement and internal cystic areas are more common in phyllodes tumors than in fibroadenomas. Results of FNA biopsy have been shown to differentiate giant fibroadenoma and phyllodes tumor [23] . However, in some cases, FNA biopsy findings may not dif ferentiate phyllodes tumor from fibro adenoma, and excisional biopsy may be needed in cases of masses that have equivocal findings of fibroadenoma on sonography [24] . Four of five tumors in our study not benign according to the Stavros sonographic criteria were subjected to excisional biopsy within 1 month of sonography and were diagnosed as benign phyllodes tumors. One 5.2-cm mass benign according to the Stavros criteria and diag nosed as fibroadenoma with previous tissue diagnosis continued to grow for 1 year and therefore was subjected to excisional biopsy, which revealed benign phyllodes tumor.
Lactating adenomas are benign stromal tumors that typically occur during the third trimester of pregnancy through the period of lactation, as encountered in two of our patients. Lactating adenoma usually regresses spontaneously after cessation of breastfeeding. Differentiation of lactating adenoma from lactational changes in a preexisting fibroadenoma is possible because changes in a fibroadenoma tend to be focal while the underlying characteristic archi tec ture of the tumor is preserved. The sonographic features of lactating adenoma have been described as nonspecific and can mimic those of a malignant tumor [25] . Core biopsy often is needed to confirm the diagnosis.
Adenocarcinoma of the breast is extremely rare in children and accounts for less than 1% of breast masses [7] . It presents as a palpable breast mass mostly in girls in the first decade of life [7] . Malignant breast masses in children and adolescents are more likely to be metastatic than primary in origin [3] . Metastatic breast lesions typically are secondary to lymphoma, leukemia, rhab do myosarcoma, and neuroblastoma and have a nonspecific sono graphic appearance [4, 7] .
Some authors [14, 26] report that children with breast masses can be treated con servatively for two menstrual cycles, until adulthood, or until the mass shows rapid growth. Bower et al. [27] in 1976 and West et al. [14] in 1995 in studies with 134 and 74 children, respectively, undergoing operative procedures for breast abnormalities proposed that Breast Sonography in Adolescents breast biopsy is rarely indicated for a distinct mass lesion in the prepubertal breast but that breast mass lesions in adolescent girls necessitate excisional biopsy. Pacinda and Ramzy [2] in 1998 reported findings of FNA biopsy of 302 patients 21 years old or younger. No cases of malignancy or phyllodes tumors were encountered in the study. Those investigators concluded that FNA biopsy can play an important role in the conservative management of breast masses in children and adolescents. Because fibro adenoma can regress spontaneously and is not associated with increased risk of malignancy, Yilmaz et al. [24] and Ciatto et al. [28] recommend conservative management with no special surveillance of children and adolescents with breast masses that resemble fibroadenoma sonographically, if there is no risk of cancer.
The National Cancer Institute [29] states that most tumors that involve the breast during childhood are benign (noncancerous) fibroadenoma that can be watched for change without biopsy. When they undergo sudden, rapid growth, such tumors can exhibit malignant change and are called phyllodes tumors, which necessitate biopsy or surgical removal. Gordon et al. [30] , in a study of solid breast masses diagnosed as fibroadenoma at FNA biopsy, concluded that these tumors can be safely observed with sonography if the volume growth rate is less than 16% per month in persons younger than 50 years. In that study, all excised masses with slower growth proved benign at histologic examination.
We found that sonographic findings were not predictive of the histologic diagnosis of a solid benign breast mass. The Stavros sonographic criteria, however, were helpful for predicting benignity of 11 (65%) of 17 breast masses on which histopathologic diagnosis was performed. Moreover, 35% of the solid breast masses in our study with findings suggestive of malignancy that were subjected to tissue biopsy also were proved benign. On the basis of our findings and the low incidence (0.025%) of malignant breast masses in children and adolescents reported by the National Cancer Institute, we conclude that excisional biopsy may not always be necessary for adolescents who present with solid breast masses that appear benign according to the Stavros sonographic criteria. Future studies of conservative management with sequential breast sonographic exam inations for follow-up of solid breast masses that have benign sonographic features are warranted to further understanding of the course of these tumors in children and adolescents. Excisional biopsy may then be reserved for solid breast masses that exhibit progressive growth or are encountered in children or adolescents with either a known primary malignant tumor or a family history of cancer.
